Trehalose given orphan drug designation by the EMA for the treatment of Sanfilippo syndrome

Sanfilippo syndrome also known as Mucopolysaccharidosis type III is a progressive disorder of central nervous system characterised by deterioration of neurological function. Positive opinion for this disaccharide is expected to be approved by European Commission within 30 days.


Biospace Inc.